tiprankstipranks
Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ:DMII
US Market
DMII
Drugs Made In America Acquisition II Corp.
RESEARCH TOOLSreports

Drugs Made In America Acquisition II Corp. (DMII) Income Statement

1 Followers

Drugs Made In America Acquisition II Corp. Income Statement

Last quarter (Q1 2026), Drugs Made In America Acquisition II Corp.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q1, Drugs Made In America Acquisition II Corp.'s net income was $4.34M. See Drugs Made In America Acquisition II Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 1.30M$ 151.72K
Depreciation and Amortization
$ 0.00$ 0.00
EBITDA
$ -1.30M$ -151.72K
Operating Income
$ -1.30M$ -151.72K
Other Income/Expenses
$ 5.49M$ 0.00
Pretax Income
$ 4.19M$ -151.72K
Net Income
$ 4.19M$ -151.72K
Per Share Metrics
Basic EPS
$ 0.16$ 0.00
Diluted EPS
$ 0.15$ 0.00
Weighted Average Shares Outstanding
 13.29M 63.70M
Weighted Average Shares Outstanding (Diluted)
 13.29M 63.70M
Currency in USD

Drugs Made In America Acquisition II Corp. Earnings and Revenue History